EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss of $0.62, Revenues Beat

Go back to EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss of $0.62, Revenues Beat
(NASDAQ: EYPT) Delayed: 3.99 +0.54 (15.65%)
Previous Close $3.45    52 Week High
Open $3.57    52 Week Low
Day High $4.01    P/E N/A 
Day Low $3.50    EPS
Volume 6,975,491